Biovica International AB (publ) (STO:BIOVIC.B)
0.4390
+0.0030 (0.69%)
At close: Feb 10, 2026
Biovica International AB Employees
Biovica International AB had 24 employees as of October 31, 2025. The number of employees decreased by 3 or -11.11% compared to the same quarter last year.
Employees
24
Change
-3
Growth
-11.11%
Revenue / Employee
412.13K SEK
Profits / Employee
-3.19M SEK
Market Cap
128.15M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Oct 31, 2025 | 24 | -3 | -11.11% |
| Jul 31, 2025 | 25 | -2 | -7.41% |
| Apr 30, 2025 | 27 | -5 | -15.63% |
| Jan 31, 2025 | 26 | -11 | -29.73% |
| Oct 31, 2024 | 27 | -10 | -27.03% |
| Jul 31, 2024 | 27 | -9 | -25.00% |
| Apr 30, 2024 | 32 | -3 | -8.57% |
| Jan 31, 2024 | 37 | 4 | 12.12% |
| Oct 31, 2023 | 37 | 10 | 37.04% |
| Jul 31, 2023 | 36 | 10 | 38.46% |
| Apr 30, 2023 | 35 | 7 | 25.00% |
| Jan 31, 2023 | 33 | 7 | 26.92% |
| Oct 31, 2022 | 27 | 3 | 12.50% |
| Jul 31, 2022 | 26 | 3 | 13.04% |
| Apr 30, 2022 | 28 | 8 | 40.00% |
| Jan 31, 2022 | 26 | 6 | 30.00% |
| Oct 31, 2021 | 24 | 3 | 14.29% |
| Jul 31, 2021 | 23 | 2 | 9.52% |
| Apr 30, 2021 | 20 | 3 | 17.65% |
| Jan 31, 2021 | 20 | 4 | 25.00% |
| Oct 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IRLAB Therapeutics AB | 31 |
| Sprint Bioscience AB | 29 |
| NextCell Pharma AB | 24 |
| Alligator Bioscience AB | 13 |
| Karolinska Development AB | 8 |
| Simris Group AB (PUBL) | 6 |
| Isofol Medical AB | 6 |
| Active Biotech AB | 5 |